MARSHALL, Texas – A federal jury has awarded biotechnology company Seagen Inc. $41.8 million in a patent infringement lawsuit against Daiichi Sankyo Co. LTD, for infringing a cancer treatment pharmaceutical patent developed by Seagen. The four-day trial took place in U.S. Chief Judge Rodney Gilstrap’s courtroom in the U.S. District Court for the Eastern District of Texas in Marshall. As…
read more